Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 15, 2022 | Post-IPO Equity | $100M | — | — | — | Detail |
Feb 8, 2021 | Post-IPO Equity | $110.01M | — | — | — | Detail |
Jan 29, 2020 | Post-IPO Equity | $26.50M | — | — | — | Detail |
Jun 22, 2018 | Post-IPO Equity | $42M | — | — | — | Detail |
Sep 28, 2016 | Post-IPO Equity | $11.50M | — | — | — | Detail |
Jun 29, 2015 | IPO | $60M | — | — | — | Detail |
Mar 31, 2015 | Secondary Market | $12.41M | — | — | — | Detail |
Nov 14, 2013 | Series B | $32.40M | 5 | Lightstone Ventures | — | Detail |
Feb 6, 2013 | Series Unknown | $9M | 4 | — | — | Detail |
Apr 4, 2012 | Grant | $120K | — | — | — | Detail |
Dec 13, 2011 | Series A | $8M | 4 | — | — | Detail |
Dec 8, 2010 | Series A | $14.50M | 4 | Advanced Technology Ventures , Clarus Ventures , MedImmune Ventures , SV Health Investors | — | Detail |
Apr 21, 2010 | Series A | $39M | 4 | Clarus Ventures , MedImmune Ventures , SV Health Investors | — | Detail |
Jan 18, 2010 | Debt Financing | $2M | — | — | — | Detail |
Jan 15, 2010 | Debt Financing | $2.09M | — | — | — | Detail |